rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Elicio Therapeutics, Inc.

ELTX · Nasdaq

Health CareBiotechnologyNot moving yet

ELTX stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 18 weeks. It is 75.5% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 18
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
49 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders49+4 on the quarter
New · exited25 · 22
Reported value$15.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Knoll Capital Management, LLCadded · filed 14 Aug 20261,211,957$4.7M+581,042+92.1%
BlackRock, Inc.added · filed 7 Aug 2026766,005$3.0M+715,408+1413.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026572,151$2.2M+53,513+10.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026311,354$1.2M+176,190+130.4%
STATE STREET CORPadded · filed 7 Aug 2026179,420$702K+128,800+254.4%
NORTHERN TRUST CORPadded · filed 13 Aug 2026130,162$509K+70,428+117.9%
Ikarian Capital, LLCnew · filed 14 Aug 2026100,000$391K+100,000
VANGUARD PORTFOLIO MANAGEMENT LLCnew · filed 13 Aug 202688,905$348K+88,905
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202688,062$344K+18,873+27.3%
ALLIANCEBERNSTEIN L.P.new · filed 14 Aug 202681,280$318K+81,280
30 Jun 2023 – 30 Jun 2026
143148Jun 23Mar 24Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Allen Nissenson Company insiderDirector · last 31 Aug 20262 · 0
Carol Gail Ashe Company insiderDirector · last 31 Aug 20260 · 0
Jay Venkatesan Company insiderDirector · last 31 Aug 20269 · 2
Julian Adams Company insiderDirector · last 31 Aug 20260 · 0
Karen J. Wilson Company insiderDirector · last 31 Aug 20260 · 0
Robert R. Ruffolo Company insiderDirector · last 31 Aug 20260 · 0
Yekaterina Chudnovsky Company insiderDirector, 10% owner · last 31 Aug 20260 · 0
Christopher Haqq Company insiderOfficer · last 16 Jul 20260 · 0
Peter DeMuth Company insiderChief Scientific Officer · last 16 Jul 20260 · 0
Preetam Shah Company insiderOfficer · last 16 Jul 20260 · 0
Robert Connelly Company insiderCEO, President and Director · last 16 Jul 20260 · 0
Gkcc, Llc Company insider10% owner · last 19 Mar 20241 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Debt to equityFY 2025 · to 31 Dec 20256.11×
Share count trendFY 2025 · to 10 Mar 20263.3%
Cash and equivalentsFY 2025 · to 31 Dec 2025$18.6M
Free cash flowFY 2025 · to 31 Dec 2025−$37.0M

Analyst forecasts

No analyst forecasts yet.